InvestorsHub Logo
Followers 4
Posts 123
Boards Moderated 0
Alias Born 12/13/2008

Re: None

Monday, 10/07/2013 9:01:03 AM

Monday, October 07, 2013 9:01:03 AM

Post# of 5918
News Breaks
October 7, 2013
07:01 EDT GWPH GW Pharmaceuticals price target raised to $65 from $22 at Lazard Capital
Lazard Capital raised its price target significantly for GW Pharmaceuticals to $65 citing the company's orphan program for epilepsy. The firm calls GW one of the most compelling opportunities its ever seen and keeps a Buy rating on the stock.

www.theflyonthewall.com/permalinks/entry.php/GWPHid1896615/GWPH-GW-Pharmaceuticals-price-target-raised-to--from--at-Lazard-Capital